ICG-guided lymphatic mapping in Esophageal Squamous Cell Carcinoma

Near-Infrared Fluorescent Image-guided lymphatic mapping in Esophageal Squamous Cell Carcinoma

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900024114

Enrollment

Unknown

Registered

2019-06-26

Start date

2019-06-21

Completion date

Unknown

Last updated

2019-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal cancer

Interventions

Gold Standard:Postoperative immunohistochemical pathology of lymph nodes

Index test:Sentinel lymph node

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Esophageal thoracic squamous cell carcinoma

Exclusion criteria

Exclusion criteria: Esophageal adenocarcinoma

Design outcomes

Primary

Measure	Time frame
Sentinel lymph node;SEN, SPEN, ACC, AUC of ROC;	—

Countries

China

Contacts

Public ContactZhigang Li

Shanghai Jiao Tong University

dixu@njmu.edu.cn+86 15852920568

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026